SHELBY YOUNGBLOOD: Open Payments
NPI 1881303667 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 18 payments from 13 companies in 2025. Trend: 2023 $704 · 2024 $379 · 2025 $451
Food & beverage: $350Education: $101
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 1 | $101 |
| Novartis Pharmaceuticals Corporation | 4 | $98 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Aveo Pharmaceuticals, Inc. | 1 | $36 |
| Daiichi Sankyo Inc. | 2 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Incyte Corporation | 1 | $21 |
| GENZYME CORPORATION | 1 | $21 |
| BeOne Medicines USA, Inc. | 1 | $21 |
| Geron Corporation | 1 | $20 |
Products named: PLUVICTO, LUTATHERA, FOTIVDA, Enhertu, LIBTAYO, MONJUVI, SARCLISA, BRUKINSA.
Industry payments across OK — which companies pay providers there.
